A · AGILENT TECHNOLOGIES INC.

Back to holdings

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems.

Close · 3M

+30.48%

Held by 1 AI ETF

AIEQ0.460%

as of Sep 4

Signal performance

Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.

Buy signals20

Win rate65% (13/20)

Avg buy return+4.82%

AIEQnow 0.460% of fund2 signals

AIEQ · Weight decrease · 2d

weight 0.480% → 0.460% (-0.020 pp)·stock up 6.7% in the 30 days before

Sep 4·entry $150.86·now $150.86

0.00%

since Sep 4

AIEQ · New entry · 1d

stock down 1.9% in the 30 days before

Jul 1·entry $133.39·now $150.86Chased

+13.10%

since Jul 1

AIVLno longer held28 signals

AIVL · Exit · 1d

weight 0.824% → 0 (exited)·stock up 8.8% in the 30 days before

Sep 2·entry $151.39·now $150.86

-0.35%

since Sep 2

AIVL · Accumulation · 5d

weight 0.789% → 0.840% (+0.051 pp)·stock up 12.4% in the 30 days before

Aug 27·entry $157.69·now $150.86Fresh

-4.33%

since Aug 27

AIVL · Accumulation · 5d

weight 0.787% → 0.822% (+0.035 pp)·stock up 10.3% in the 30 days before

Aug 26·entry $155.08·now $150.86Fresh

-2.72%

since Aug 26

AIVL · Accumulation · 6d

weight 0.780% → 0.826% (+0.045 pp)·stock up 12.2% in the 30 days before

Aug 25·entry $154.77·now $150.86Fresh

-2.53%

since Aug 25

AIVL · Accumulation · 5d

weight 0.787% → 0.818% (+0.032 pp)·stock up 10.7% in the 30 days before

Aug 24·entry $153.43·now $150.86Fresh

-1.68%

since Aug 24

AIVL · Accumulation · 5d

weight 0.787% → 0.849% (+0.062 pp)·stock up 13.8% in the 30 days before

Aug 21·entry $159.00·now $150.86Fresh

-5.12%

since Aug 21

AIVL · Weight increase · 4d

weight 0.780% → 0.835% (+0.055 pp)·stock up 17.1% in the 30 days before

Aug 20·entry $156.30·now $150.86Fresh

-3.48%

since Aug 20

AIVL · Weight increase · 3d

weight 0.780% → 0.825% (+0.045 pp)·stock up 17.0% in the 30 days before

Aug 19·entry $155.41·now $150.86Fresh

-2.93%

since Aug 19

AIVL · Weight increase · 2d

weight 0.780% → 0.789% (+0.009 pp)·stock up 14.0% in the 30 days before

Aug 18·entry $148.44·now $150.86Fresh

+1.63%

since Aug 18

AIVL · Accumulation · 5d

weight 0.751% → 0.796% (+0.045 pp)·stock up 11.5% in the 30 days before

Aug 11·entry $149.49·now $150.86Fresh

+0.92%

since Aug 11

AIVL · Weight increase · 3d

weight 0.749% → 0.790% (+0.041 pp)·stock up 10.7% in the 30 days before

Aug 10·entry $148.72·now $150.86Fresh

+1.44%

since Aug 10

AIVL · Weight increase · 2d

weight 0.749% → 0.774% (+0.025 pp)·stock up 9.3% in the 30 days before

Aug 7·entry $145.97·now $150.86Drifting

+3.35%

since Aug 7

AIVL · Weight increase · 3d

weight 0.711% → 0.763% (+0.052 pp)·stock up 10.3% in the 30 days before

Jul 23·entry $139.74·now $150.86Drifting

+7.96%

since Jul 23

AIVL · Weight increase · 2d

weight 0.711% → 0.730% (+0.019 pp)·stock up 5.5% in the 30 days before

Jul 22·entry $133.46·now $150.86Chased

+13.04%

since Jul 22

AIVL · Weight decrease · 4d

weight 0.743% → 0.711% (-0.031 pp)·stock up 4.8% in the 30 days before

Jul 20·entry $130.26·now $150.86

+15.81%

since Jul 20

AIVL · Weight decrease · 3d

weight 0.743% → 0.716% (-0.027 pp)·stock up 2.4% in the 30 days before

Jul 17·entry $131.46·now $150.86

+14.76%

since Jul 17

AIVL · Weight decrease · 2d

weight 0.743% → 0.736% (-0.007 pp)·stock up 4.2% in the 30 days before

Jul 16·entry $136.10·now $150.86

+10.84%

since Jul 16

AIVL · Weight increase · 2d

weight 0.713% → 0.734% (+0.021 pp)·stock down 0.9% in the 30 days before

Jul 10·entry $134.29·now $150.86Chased

+12.34%

since Jul 10

AIVL · Weight decrease · 2d

weight 0.740% → 0.711% (-0.029 pp)·stock down 4.9% in the 30 days before

Jul 6·entry $130.60·now $150.86

+15.51%

since Jul 6

AIVL · Accumulation · 5d

stock down 3.2% in the 30 days before

Jul 2·entry $130.69·now $150.86Chased

+15.43%

since Jul 2

AIVL · Accumulation · 5d

stock down 1.9% in the 30 days before

Jul 1·entry $133.39·now $150.86Chased

+13.10%

since Jul 1

AIVL · Weight increase · 4d

stock up 17.4% in the 30 days before

Jun 26·entry $136.01·now $150.86Chased

+10.92%

since Jun 26

AIVL · Weight increase · 3d

stock up 17.8% in the 30 days before

Jun 25·entry $135.51·now $150.86Chased

+11.33%

since Jun 25

AIVL · Weight increase · 2d

stock up 14.5% in the 30 days before

Jun 24·entry $131.63·now $150.86Chased

+14.61%

since Jun 24

AIVL · Weight decrease · 7d

stock up 11.2% in the 30 days before

Jun 22·entry $126.49·now $150.86

+19.27%

since Jun 22

AIVL · Weight decrease · 7d

stock up 14.9% in the 30 days before

Jun 18·entry $127.06·now $150.86

+18.73%

since Jun 18

AIVL · Weight decrease · 6d

stock up 14.9% in the 30 days before

Jun 16·entry $128.34·now $150.86

+17.55%

since Jun 16

AIVL · Weight decrease · 5d

stock up 15.2% in the 30 days before

Jun 12·entry $129.84·now $150.86

+16.19%

since Jun 12

Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.

Buffett-style framework

Fails the frameworkas of Jul 5

AI ETFs like AIVL and AIEQ have shown recent accumulation and new entry into Agilent Technologies, signaling a positive outlook. This contrasts with the framework's 'Fail' verdict, which is primarily driven by the lack of a margin of safety and incomplete financial health data.

Circle of CompetenceAgilent's position in the stable life sciences tools and services sector, driven by recurring consumables and services, allows for reasonably predictable long-term cash flow projections.
Economic MoatThe company benefits from strong switching costs due to integrated, complex instruments and high customer revalidation costs, supported by a reputable brand in a specialized market.
ManagementDetailed information on management's candor, capital allocation history, or ownership stake is not provided to assess this criterion.
Financial HealthInsufficient data on 10-year average ROE, operating margins, owner earnings, and specific debt metrics prevent a comprehensive assessment of long-term financial health, and the high EV/EBITDA ratio warrants further scrutiny.
Margin of SafetyThe high valuation multiples (PER 26.67, PBR 6.16, EV/EBITDA 36.12) suggest the company is trading at a significant premium, leaving no discernible margin of safety.

Agilent Technologies operates within a predictable industry and possesses a strong economic moat due to high switching costs and brand power. However, the analysis is hampered by a lack of complete financial history to confirm long-term health and capital allocation. Crucially, the current market price does not offer a margin of safety, as indicated by elevated valuation multiples.

Educational interpretation generated by AI applying frameworks Warren Buffett documented in his shareholder letters and other public writings. Not a statement by Mr. Buffett or Berkshire Hathaway, and not investment advice.